Post-β-receptor impairment in the regulation of myofibrillar Ca2+ sensitivity in tachypacing-induced canine failing heart

S. Satoh, N. Suematsu, Y. Ueda, H. Tsutsui, K. Egashira, A. Takeshita, N. Makino

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Although one of the salient abnormalities in signal transduction of failing myocardium is downregulation of the β-adrenergic receptor, the extent of presentation of downstream pathways distal to β-receptors is misunderstood. We addressed this question in tachypacing-induced canine failing heart by assessing changes in myofibrillar Ca2+ sensitivity and troponin I phosphorylation. At a basal state, no significant difference in myofibrillar Ca2+ sensitivity was found between normal and failing hearts. Isoproterenol 8-bromo-cylic adenosine monophosphate (cAMP), and 8-bromo-cAMP isobutylmethylxantine all significantly decreased the Ca2+ sensitivity in the normal, but not in the failing, heart. EMD57033 (10 μM), a myofibrillar Ca2+ sensitizer increased the Ca2+ sensitivity to a similar extent in both groups. The troponin I phosphorylation levels were significantly decreased in the failing heart. These results suggest that abnormalities of the β-adrenergic signaling system exist not only at the receptor level but also at downstream steps after cAMP production.

Original languageEnglish
Pages (from-to)88-97
Number of pages10
JournalJournal of Cardiovascular Pharmacology
Issue number1
Publication statusPublished - Jan 12 2002

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Post-β-receptor impairment in the regulation of myofibrillar Ca<sup>2+</sup> sensitivity in tachypacing-induced canine failing heart'. Together they form a unique fingerprint.

Cite this